Ipecac
Active ingredient · 2 therapeutic classes
Sold as Triple Flu Defense · Umcka FastActives Berry · Cold Flu Relief Berry
- Drug class
- Expectorants
- Availability
- Over-the-counter
- Routes
- Oral
- Markets covered
- 1
- Products on record
- 5
- FDA reports (12 mo)
- 55
Overview
Plain-language summary, compiled from the cited regulatory records
Ipecac is an active ingredient classified as an expectorant [1]. It is approved for use as indicated by a physician or for the condition listed in its labeling [1].
In the market, Ipecac can be found under various brand names, including Cold Flu Relief Berry, Triple Flu Defense, and Umcka FastActives Berry [1]. Over the past 12 months, there have been 55 adverse event reports associated with this ingredient [2]. The most frequently reported reactions include eye pain, fatigue, diarrhea, nausea, and dizziness [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 5 | May 6, 2026 |
USUnited States· FDA
5 products
Uses
INDICATIONS
Condition listed above or as directed by the physician
How to take
Drug interactions
Known interactions involving Ipecac. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]FDA DailyMed · 104080d7-4de4-47… · revised September 26, 2021 [PDF]
- [2]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.